In Section C, individuals will get ABBV-744 and oral navitoclax. In Section D, members will obtain ABBV-744 and ruxolitinib. Individuals will obtain treatment till ailment progression or perhaps the members are not able to tolerate the study drugs. after which encourage H3K27Ac at this area. Chromatin hyperacetylation could improve the https://sandrax110kwg3.myparisblog.com/profile